华领医药-B(02552)盘中涨近10%，截至发稿，涨6.69%，报3.03港元，成交额1066.1万港元。消息面上，3月3日，华领医药宣布，其全球首创新药葡萄糖激酶激活剂(GKA)多格列艾汀(dorzagliatin)(商品名：MYHOMSIS，华领片)已获香港卫生署批准上市，用于治疗成人2型糖尿病。这一成果标志着华领医药以香港为枢纽，从中国正式进军东南亚及全球市场的战略布局已迈出关键一步。
Source Link华领医药-B(02552)盘中涨近10%，截至发稿，涨6.69%，报3.03港元，成交额1066.1万港元。消息面上，3月3日，华领医药宣布，其全球首创新药葡萄糖激酶激活剂(GKA)多格列艾汀(dorzagliatin)(商品名：MYHOMSIS，华领片)已获香港卫生署批准上市，用于治疗成人2型糖尿病。这一成果标志着华领医药以香港为枢纽，从中国正式进军东南亚及全球市场的战略布局已迈出关键一步。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.